DFX Intelligence

Data Factory

VentureFirmpe with venture activity · probableregistered_investment_adviser

1315 Capital

Venture Capital

Philadelphia, PA

1315 Capital invests in commercial-stage healthcare: services, pharma/medtech, outsourcing, and health & wellness—built for growth.

This is the graph view. The full profile, with its team, deals and sources, is on Venture Capital.Open the full profile →

Search this name across graphsid dfx:vc:ce017f83-33b1-45a6-9127-422aca54160c

Data as of Sep 17, 2026 (this record's last observation) from federal regulator filings, firm and issuer disclosures. Page built Sep 21, 2026, 3:44 PM UTC and rebuilt at most every 15 minutes.

Relationships: 69
Dated events: 6
On other graphs: 4
Observed: Sep 12, 2026 to Sep 17, 2026
38 observations

Across DFX

same identity by shared identifier, citation, or a bridge measured by hand

Independent Sponsorsidentity

1315 Capital

Capital provider to sponsors · cited, shared crd

Private Equityidentity

1315 Capital

Private equity manager · cited, shared crd

RIA / Wealth Managementidentity

1315 CAPITAL

Registered adviser · cited, shared crd

Allocatorsidentity

1315 Capital

Manager with allocator commitments · cited, shared crd

Facts

fact = as filed or announced; derived = computed by DFX; estimate = a band, never a point

Funds: 5
Vintages: 2015 to 2022
Reported GAV: $578Mgross asset value on Form ADV; never dry powder
Regulatory AUM: $1.1B
Funds with fundraising evidence: 0derived
Investments: 37
Portfolio companies: 37
Investments, 12m: 37
Partner-attributed: 0
People: 25
Investment professionals: 19derived
Co-investors: 0derived
LP relationships: 6
Stated sectors: healthcare,biotech,medtech,climateas stated by the firm
Stated geography: philadelphia
Latest Form D: Feb 14, 2018
Latest ADV filing: Mar 25, 2024
Website: 1315capital.com

Funds

Fund	Vintage	Lifecycle	Form D sold	GAV	LPs
1315 Capital III LP	2022	Active deployment	n/a	n/a	1
1315 Capital Fund III	2022	Active deployment	n/a	n/a	2
1315 Capital Aiv, LP	2019	Mature	n/a	$842,667	0
1315 Capital II LP	2018	Harvest	$300M	$282M	1
1315 Capital, LP	2015	Harvest	$179M	$295M	0

Investments

round size is never this investor's check

Company	State	Stage	Round size	Partner	Attribution	Observed
Coating Place	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Codis	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Colorescience	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Corticare	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Encore Dermatology	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Experic, LLC	Nj	n/a	n/a	n/a	Unknown	Sep 16, 2026
Genoptix	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Homestead Smart Health Plans	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Innovative Health	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Integration Health	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Interpace Biosciences, Inc.	Nj	n/a	n/a	n/a	Unknown	Sep 16, 2026
Jds Therapeutics	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Medivant Healthcare	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Miradry	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Misonix	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Mosaic Diagnostics	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Neuronetics	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Nu Tek Biosciences	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Nutrisense	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Onkos Surgical	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Primrose Bio, Inc.	CA	n/a	n/a	n/a	Unknown	Sep 16, 2026
Prosciento	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Reaction Biology	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Restorative Therapies	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Scisafe	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026

Co-investors

pairs come only from shared rounds and listings

Investor	Co-investor	Shared deals	Shared companies	Last observed	Strength
RC Capital	1315 Capital	2	2	Sep 16, 2026	Recurring
1315 Capital	Ascension Ventures	1	1	Sep 17, 2026	One time
1315 Capital	EW Healthcare Partners	1	1	Sep 16, 2026	One time

Relationships

Invested in (37)

→ Onkos SurgicalCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ Coating PlaceCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ CodisCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ ColorescienceCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ CorticareCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ Encore DermatologyCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ Experic, LLCCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ GenoptixCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ Homestead Smart Health PlansCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ Innovative HealthCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ Integration HealthCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ Interpace Biosciences, Inc.CompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ Jds TherapeuticsCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ Medivant HealthcareCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ MiradryCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ MisonixCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ Mosaic DiagnosticsCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ NeuroneticsCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ Nu Tek BiosciencesCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ NutrisenseCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ Primrose Bio, Inc.CompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ ProscientoCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ Reaction BiologyCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ Restorative TherapiesCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ ScisafeCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ Seraphina TherapeuticsCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ Spineology IncCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ Surmodics Fka BiocoatCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ Triplering TechnologiesCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ UspharmaCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
and 7 more

Employs (25)

→ Rob SchrepferPersonOperating Team Member
factThe subject's own site
→ Healthcare FocusPersonInvestment Criteria
factThe subject's own site
→ Scott CramerPersonOperating Team Member
factThe subject's own site
→ Michael SatowPersonOperating Team Member
factThe subject's own site
→ Value CreationPersonPortfolio
factThe subject's own site
→ Adele C OlivaPersonFounding Partner
factThe subject's own site
→ Michael KobyPersonFounding Partner
factThe subject's own site
→ Matthew ReberPersonPartner
factThe subject's own site
→ Brian SchwenkPersonChief Financial Officer & Chief Compliance Officer
factThe subject's own site
→ Jacqueline AkpanPersonController
factThe subject's own site
→ Jake BakerPersonBusiness Development Associate
factThe subject's own site
→ Patricio BeltranPersonAnalyst
factThe subject's own site
→ Jordan BrownPersonPrincipal
factThe subject's own site
→ Morgan FugePersonOffice Manager
factThe subject's own site
→ Ryan KrausPersonVice President
factThe subject's own site
→ Ian B. LiPersonPrincipal
factThe subject's own site
→ Craig MatturroPersonPrincipal
factThe subject's own site
→ Marisa PowellPersonAssociate
factThe subject's own site
→ Russ RapaportPersonAssociate
factThe subject's own site
→ Jamie RichardsonPersonDirector of Business Development
factThe subject's own site
→ Joe SchlitzPersonAssociate
factThe subject's own site
→ Tom BurnellPersonOperating Team Member
factThe subject's own site
→ Brian Richard SchwenkPersonCco & Cfo
Feb 1, 2015 to presentfactForm ADV
→ M Michael KobyPersonPartner
Feb 1, 2015 to presentfactForm ADV
→ Adele Cirone OlivaPersonManager
Feb 1, 2015 to presentfactForm ADV

Lp of (2)

← Los Angeles City Employees' Retirement SystemLimited partnerprimary
factPlan disclosure
← Massachusetts Pension Reserves Investment Management BoardLimited partnerprimary
factPlan disclosure

Manages (5)

→ 1315 Capital Fund IIIFund
factPlan disclosure
→ 1315 Capital III LPFund
factPlan disclosure
→ 1315 Capital, LPFundVenture Capital Fund
Mar 18, 2015 to presentfactForm ADV
→ 1315 Capital II LPFundVenture Capital Fund
Mar 23, 2018 to presentfactForm ADV
→ 1315 Capital Aiv, LPFundVenture Capital Fund
Mar 27, 2019 to presentfactForm ADV

Dated events

3 bookkeeping events (roster, classification and holdings changes) folded below

Occurred
Dec 31, 2025
LP commitment disclosed
LACERS reports 1315 Capital Fund: $10,000,000 committed, vintage 2015, net IRR 16.4%, 2.22x
Los Angeles City Employees' Retirement System Plan disclosureobserved 7 days ago
$10.0M
Occurred
Jun 30, 2025
LP commitment disclosed
Mass PRIM lists 1315 Capital among its private equity managers
Massachusetts Pension Reserves Investment Management Board Plan disclosureobserved 8 days ago
Occurred
Mar 18, 2015
Adviser's first ADV filing
1315 Capital first filed Form ADV (ERA, venture capital fund adviser exemption)
Form ADVobserved 9 days ago

Show 3 bookkeeping events

Occurred
Mar 27, 2019
1315 Capital Aiv, LP first reported on Form ADV by 1315 Capital (Venture Capital Fund), GAV $370,018
Occurred
Mar 23, 2018
1315 Capital II LP first reported on Form ADV by 1315 Capital (Venture Capital Fund), GAV $306,000,000
Occurred
Mar 18, 2015
1315 Capital, LP first reported on Form ADV by 1315 Capital (Venture Capital Fund), GAV $60,050,000

Who to call

the organisation, the role and the published line, with the filing or website that published it; revealed to signed-in accounts

The firm's published line

Revealable: 1 business phone (Form ADV), 1 website (Form ADV), 1 work email (firm website) · as of 2026-09-17

Also named here, with no published line of their own (reach them through the firm): Rob Schrepfer (Operating Team Member), Healthcare Focus (Investment Criteria), Scott Cramer (Operating Team Member), Michael Satow (Operating Team Member), Value Creation (Portfolio), Adele C Oliva (Founding Partner), Michael Koby (Founding Partner), Matthew Reber (Partner), Brian Schwenk (Chief Financial Officer & Chief Compliance Officer), Jacqueline Akpan (Controller), Jake Baker (Business Development Associate), Patricio Beltran (Analyst).

Who to call is the organisation, the person's role and the line they published themselves: a business phone, office address, website or profile link from Form ADV, Form 13F or their own website, with that source named on every value. The counts above are what a reveal returns; a personal email is rarely published, so most reveals are the firm's line. Never data bought from a provider, never anything personal. Reveals by plan

Provenance

Graph: Venture Capital
Canonical id: dfx:vc:ce017f83-33b1-45a6-9127-422aca54160c
First observed: Sep 12, 2026
Last observed: Sep 17, 2026 4 days ago
Source families: Federal regulator filings, Firm and issuer disclosures
2 registered feeds stand behind this record; each fact above carries its own dates and, where the publisher serves one, its document.
Resolution: Identity across graphs by shared identifier (CRD, CIK, EIN, ADV fund id, individual CRD) or citation; a name match is shown as a candidate and never merged.

1315 Capital

Venture Capital

Philadelphia, PA

1315 Capital invests in commercial-stage healthcare: services, pharma/medtech, outsourcing, and health & wellness—built for growth.

This is the graph view. The full profile, with its team, deals and sources, is on Venture Capital.Open the full profile →

Search this name across graphsid dfx:vc:ce017f83-33b1-45a6-9127-422aca54160c

Data as of Sep 17, 2026 (this record's last observation) from federal regulator filings, firm and issuer disclosures. Page built Sep 21, 2026, 3:44 PM UTC and rebuilt at most every 15 minutes.